An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...

Celebrities like Matthew Perry, Chrissy Teigen and others have been open about using ketamine infusion therapy to help treat ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's nasal spray, Spravato, to allow it to be used ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

While ketamine is celebrated as a breakthrough depression treatment, new research highlights a significant rise in its ...

The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...

Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's ...

Ketamine disrupts abnormal brain activity, offering long-term relief for Parkinson’s dyskinesia in early clinical trials.

This can then be followed by a dexmedetomidine infusion (1–2 μg/kg/hr) with supplemental bolus doses of ketamine (0.5–1 mg/kg) as needed. Conclusions: The available literature except for one ...

Dr. David Mahjoubi, a highly respected board-certified anesthesiologist and the founder of Ketamine Healing Clinic of Los Angeles and OC, has been recognized as a 2025 Top Patient Rated Doctor by Find ...